Benchmark Holdings plc provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide. It operates through Animal Health, Breeding and Genetics, Advanced Animal Nutrition, Sustainability Science, and Technical Publishing divisions. The Animal Health division manufactures licensed vaccines and antigens for farm, aquatic, and companion animals, as well as engages in the contract manufacturing of veterinary vaccines. This division also provides bespoke vaccine technology transfer and process development services; veterinary services; and environmental services. The Breeding and Genetics division provides technical genetic services; and produces Atlantic salmon ova. The Advanced Animal Nutrition division manufactures and provides nutrition and health products to the aquaculture industry. The Sustainability Science division provides sustainable food production consultancy, technical consultancy, and assurance services. The Technical Publishing division promotes sustainable food production and ethics through online news and technical publications for agriculture and food processing sectors; and through delivery of training courses to the industries. It offers digital news, knowledge transfer, technical publishing, e-learning and technical training, and market analysis; conducts conferences and webinars; and publishes books, DVDs, and digital media. The company was founded in 2000 and is headquartered in Sheffield, the United Kingdom.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Phone+44-114-2409935
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees952
OptionableNot Optionable
Benchmark (LON:BMK) Frequently Asked Questions
What is Benchmark's stock symbol?
Benchmark trades on the London Stock Exchange (LON) under the ticker symbol "BMK."
What price target have analysts set for BMK?
2 analysts have issued 1 year price targets for Benchmark's stock. Their predictions range from GBX 77 to GBX 92. On average, they expect Benchmark's share price to reach GBX 84.50 in the next twelve months. This suggests a possible upside of 59.4% from the stock's current price. View Analyst Price Targets for Benchmark.
What is the consensus analysts' recommendation for Benchmark?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Benchmark in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Benchmark.
Has Benchmark been receiving favorable news coverage?
Media stories about BMK stock have trended somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Benchmark earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are some of Benchmark's key competitors?
Some companies that are related to Benchmark include Acreage (ACRGF), Amryt Pharma (AMYT), Cannabis Science (CBIS), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), Cosmos (COSM), Curaleaf (CURLF), Diurnal Group (DNL), Easton Pharmaceuticals (EAPH), Evgen Pharma (EVG), EVIO (EVIO), Evotec (EVT), Flower One (FLOOF) and FSD Pharma (FSDDF).
Who are Benchmark's key executives?
Benchmark's management team includes the folowing people:
- Mr. Malcolm David Foster Pye, CEO & Exec. Director (Age 61)
- Mr. Mark James Plampin, CFO & Exec. Director (Age 50)
- Mr. Roland James Bonney, Group Lead of Key Account Management (Age 54)
- Ms. Ruth Layton, Co-Founder & Head of Benchmark Sustainability Science
- Dr. Alexander Josef Raeber, Chief Scientific Officer & Exec. Director (Age 58)
How do I buy shares of Benchmark?
Shares of BMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Benchmark's stock price today?
One share of BMK stock can currently be purchased for approximately GBX 53.
What is Benchmark's official website?
How can I contact Benchmark?
Benchmark's mailing address is Benchmark House, 8 Smithy Wood Drive, SHEFFIELD, S35 1QN, United Kingdom. The company can be reached via phone at +44-114-2409935.
MarketBeat Community Rating for Benchmark (LON BMK)
MarketBeat's community ratings are surveys of what our community members think about Benchmark and other stocks. Vote "Outperform" if you believe BMK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMK will underperform the S&P 500 over the long term. You may vote once every thirty days.
